Digital Therapeutics Market Size to Amass US$ 11.82 Bn by 2027

Spread the love

Precedence Research’s latest report on the global digital therapeutics market provides an analysis for the period of 2016 to 2027, wherein, 2020 is the base year, 2016 and before is historical data, and 2020 to 2027 is the forecast period.

The global digital therapeutics market size was valued at US$ 2.69 Billion in 2019 and is projected to reach US$ 11.82 Billion by 2027, rising at a market growth (CAGR) of 20.3% during the forecast period.

Precedence Research provides an in-depth analysis of market size, share analysis, Industry growth, market valuation, market dynamics which includes drivers, restraints, opportunities, trends, challenges, market segmentation, competitive landscape, regional and country breakdowns, and strategies for digital therapeutics market. The study reviews the global industry by-products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context, and more.

The report comprises a detailed value chain analysis, which provides a comprehensive view of this market. The Porter’s Five Forces model for the global market has also been included to help understand the competitive landscape. The study covers market attractiveness analysis, wherein resin types are benchmarked based on their market value, growth rate, and general attractiveness.

Download FREE SAMPLE PAGES before Purchase https://www.precedenceresearch.com/sample/1128

Digital therapeutics is a part of health, but all digital health solutions are not digital therapeutics solutions. Basic difference between digital therapeutics and digital health is completely based on the clinical outcomes for patients. For example, digital therapeutics does not comprise of consumer health-oriented technologies that include calorie-counters and step-counters. It’s a new class of healthcare products that uses digital technology to prevent, manage, or treat medical conditions. Additionally, it uses digital health technologies in treating psychological conditions of patients. Hence, the aforementioned factors positively influence the market growth for digital therapeutics.

Growth Factors

Increasing penetration of internet usage and smartphones particularly in the developing countries estimated as the key factor to propel the market growth. For instance, India ranked 47th and 36th in 2013 and 2015 by Google Inc. for smartphone penetration. In addition, rising need to curb the increasing spending on healthcare sector also anticipated to drive the market growth over the forecast timeframe.

Furthermore, rising prevalence of chronic diseases such as diabetes, obesity, smoking cessation, and many others across the globe is the other most prominent factor that impels the market growth. As per the statistics published by the International Diabetes Federation (IDF), in every 7 seconds a person dies from diabetes and its complications. In addition to this, the total number of people suffering from diabetes anticipated to rise by 48% from 424.9 Million in 2017 to 628.6 Million by 2045. Hence diabetes and similar other chronic disease are a major threat to the economy. To curb the rate of increasing chronic diseases along with rising awareness among the public related to health and fitness is likely to boost the growth of digital therapeutics in the upcoming years.

However, the undefined payment procedures along with lack of efficient monetization strategies projected to hamper the market growth. Nonetheless, integration of digital therapeutics platform with machine learning and artificial intelligence opens up new opportunity in the sector.

Report Highlights

  • North America emerged as a global leader in 2019 owing to increasing number of reforms pertaining to curtail the rising healthcare spending across the region
  • The Asia Pacific expected to witness the fastest growth over the analysis period because of large consumer base along with rising geriatric population in the region
  • Software segment captured the largest value share based on product type for the year 2019 and projected to register the fastest growth over the analysis timeframe
  • Based on application, diabetes dominated the global market in 2019 and estimated to forecast same trend over the upcoming period due to rising prevalence of diabetes across the globe
  • Obesity is the other major concerned disease that expected to exhibit the fastest growth over the forthcoming years owing to changing eating habits largely influenced by the western pattern

Regional Snapshots

North America captured the largest market share in the global digital therapeutics market and expected to retain its position over the upcoming years. The growth of the region is mainly attributed to the increasing focus towards a patient-centric healthcare approach coupled with need to curtail the increasing spending on healthcare sector. Further, rising cases of diabetes across the region along with its cost to the economy is the other major factor that influences the market growth for digital therapeutics in the region.

On the contrary, the Asia Pacific exhibits the fastest growth rate during the forthcoming years. The significant growth of the region is mainly due to rapid urbanization and fast changing technology landscape in the region. Further, rising geriatric population in the region further impels the application developers to bring advancement and patient centric apps in the region.

Key Players & Strategies

The global digital therapeutics industry is at its niche stage; however, experiences significant merger, partnership, and new product launch & development. For instance, in September 2019, TrialCard, a company that works in conjunction with pharma manufacturers to connect patients to services and medications, announced to acquire Mango Health. The acquisition helped TrialCard to offer best engagement and adherence solution to their patients. Similarly, in July 2020, Biocon Biologics India, a biosimilars company, and Voluntis, a digital therapeutics company, announced to enter into a collaboration agreement. Under this agreement, Biocon in collaboration with Voluntis develops and distributes innovative digital therapeutic solutions for type-2 diabetes patients.

Some of the key players operating in the market are Fitbit Health Solutions, 2MORROW, Inc., Medtronic Plc., Livongo Health, Inc., Pear Therapeutics, Inc., Omada Health, Inc., Resmed, Inc. (Propeller Health), Proteus Digital Health, Inc., Welldoc, Inc., Voluntis, Inc., Canary Health Inc., Noom, Inc., Mango Health Inc., and Dthera Sciences among others.

Segments Covered in the Report:

Market Segment

By Product

  • Device
  • Software

By Sales Channel

  • Business-to-Consumer (B2C)
    • Caregiver
    • Patient
  • Business-to-Business (B2B)
    • Healthcare Provider
    • Employer
    • Others

By Application

  • Obesity
  • Diabetes
  • Central Nervous System (CNS) Disease
  • Gastrointestinal Disorder (GID)
  • Cardiovascular Disease (CVD)
  • Smoking Cessation
  • Respiratory Disease
  • Others

Regional Segment

  • North America (United States, Canada)
  • Europe (Germany, France, UK,  Italy, Russia, and Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia, Korea, and Rest of Asia Pacific)
  • Latin America (Brazil and the Rest of Latin America)
  • The Middle East and Africa (GCC, North Africa, South Africa, and Rest of the Middle East & Africa)

Purchase this Market Research Report @ https://www.precedenceresearch.com/checkout/1128

About Us:

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Steve Robber

My name is Steve Robber, I’m the Owner of Market Stats News. Steve has served in many positions at various organizations for the past seven years. Currently he is an Author at Finance.Yahoo. Contact us for a free news publication, we look forward to speaking with you!

View all posts by Steve Robber →

Leave a Reply

Your email address will not be published. Required fields are marked *